Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: Determination of the best diagnostic approach

Bone Marrow Transplantation

Volumn 38, Issue 5, 2006, Pages 371-376

  Thompson, B ^a   Salzman, D ^b   Steinhauer, J ^c   Lazenby, A J ^c   Wilcox, C M ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Colitis; Diarrhea; Graft versus host; Host disease

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; FLUDARABINE; MELPHALAN; METHOTREXATE; THIOTEPA;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON BIOPSY; COLONOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIARRHEA; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HISTOCOMPATIBILITY; HISTOPATHOLOGY; HUMAN; ILEUM; INTERMETHOD COMPARISON; INTESTINE BIOPSY; MALE; MYELOABLATIVE CONDITIONING; NAUSEA AND VOMITING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SIGMOIDOSCOPY; STEM CELL TRANSPLANTATION; SYMPTOMATOLOGY; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BIOPSY; BONE MARROW TRANSPLANTATION; CHILD; COLON; DIARRHEA; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ILEUM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33747335433     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705453     Document Type: Article

References (17)

1. Kreisel W, Herbst EW, Schwind B, Ochs A, Olschewski M, Kochling G et al. Diagnosis and grading of acute graft-versus-host disease following allogeneic bone marrow transplantation by sigmoidoscopy. Eur J Gastroenterol Hepatol 1994; 6: 723-729.
2. Bombi JA, Nadal A, Carreras E, Ramirez J, Munoz J, Rozman C et al. Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease. Am J Clin Pathol 1995; 103: 690-695.
3. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667-674.
4. Fallows G, Rubinger M, Bernstein CN. Does gastroenterology consultation change management of patients receiving hematopoietic stem cell transplantation? Bone Marrow Transplant 2001; 28: 289-294.
5. Cox GJ, Matsui SM, Lo RS, Hinds M, Bowden RA, Hackman RC et al. Etiology and outcome of diarrhea after marrow transplantation: A prospective study. Gastroenterology 1994; 107:1398-1407.
6. Goker J, Haznedaroglu IC, Chao NJ. Acute graft-versus-host disease: pathobiology and management. Exp Hematol 2001; 29: 259-277.
7. Ponec RJ, Hackman RC, McDonald GB. Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation. Gastrointest Endosc 1999; 49: 612-621.
8. Roy J, Snover D, Weisdorf S, Mulvahill A, Filipovich A, Weisdorf D. Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease. Transplantation 1991; 51: 642-646.
9. Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED. The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: A prospective study of thirteen patients. Gastroenterology 1980; 78: 764-771.
10. Santos GW, Owens AH. Production of graft-versus-host disease in the rat and its treatment with cytotoxic agents. Nature 1966; 210: 139-140.
11. Storb R, Epstein RB, Graham TC, Thomas ED. Methotrexate regimens for control of graft-versus host disease in dogs with allogeneic marrow grafts. Transplantation 1970; 9: 204-246.
12. Storb R, Deeg HJ, Pepe M, Doney K, Appelbaum F, Beatty P et al. Graft-versus-host disease prevention by methotrexate combined with cyclosporine compared to methotrexate alone in patients given marrow grafts for severe aplastic; anaemia: Long term follow-up of a controlled trial. Br J Haematol 1989; 72: 567-572.
13. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. N Eng J Med 1986; 314: 729-735.
14. Storb R, Deeg HJ, Pepe M, Appelbaum F, Anasetti C, Beatty P et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial. Blood 1989; 73: 1729-1734.
15. McDonald GB, Sale GE. The human gastrointestinal tract after allogeneic marrow transplantation. In: Sale GI, Shulman HM (eds). The Pathology of Bone Marrow Transplantation. Masson: New York, 1984, p. 83.
16. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A matched sibling donors. Transplantation 1974; 18: 295-304.
17. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.